- Report
- May 2024
- 160 Pages
Global
From €4939EUR$4,999USD£4,111GBP
- Report
- April 2024
- 140 Pages
Global
From €4939EUR$4,999USD£4,111GBP
- Report
- February 2024
- 180 Pages
Global
From €5433EUR$5,499USD£4,522GBP
- Report
- May 2024
- 200 Pages
Global
From €4101EUR$4,150USD£3,413GBP
- Report
- May 2024
- 200 Pages
Global
From €4101EUR$4,150USD£3,413GBP
- Report
- January 2024
- 200 Pages
Global
From €4101EUR$4,150USD£3,413GBP
- Report
- October 2024
- 243 Pages
Global
From €3952EUR$4,000USD£3,290GBP
- Clinical Trials
- February 2024
- 406 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- September 2024
- 110 Pages
Global
From €3500EUR$3,795USD£3,015GBP
- Report
- February 2024
- 82 Pages
Global
From €3500EUR$3,795USD£3,015GBP
- Report
- February 2024
- 97 Pages
Global
From €3500EUR$3,795USD£3,015GBP
- Report
- February 2024
- 73 Pages
Global
From €3500EUR$3,795USD£3,015GBP
- Report
- June 2024
- 144 Pages
Global
From €3280EUR$3,320USD£2,730GBP
€4101EUR$4,150USD£3,413GBP
- Report
- June 2024
- 144 Pages
Global
From €3280EUR$3,320USD£2,730GBP
€4101EUR$4,150USD£3,413GBP
- Report
- February 2024
- 157 Pages
Global
From €3518EUR$3,560USD£2,928GBP
€4397EUR$4,450USD£3,660GBP
- Report
- September 2024
- 95 Pages
Global
From €3500EUR$3,795USD£3,015GBP
- Report
- May 2024
- 224 Pages
Global
From €4935EUR$4,995USD£4,108GBP
- Report
- March 2024
- 131 Pages
Global
€4935EUR$4,995USD£4,108GBP
- Report
- September 2024
- 131 Pages
Global
From €3952EUR$4,000USD£3,290GBP
- Report
- November 2024
- 50 Pages
Global
From €2618EUR$2,650USD£2,179GBP
The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders.
The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more